Cargando…
Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics
Biological therapy is very effective for treating patients with moderate to severe inflammatory bowel disease (IBD). However, up to 40% can have primary non-response, and up to 50% of the patients can experience a loss of response to anti-tumor necrosis factor therapy. These undesirable outcomes can...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672599/ https://www.ncbi.nlm.nih.gov/pubmed/38002743 http://dx.doi.org/10.3390/jcm12227132 |